Related Experiment Videos
Complement activation by pulsed tunable dye laser in normal skin and hemangioma
F Gay-Crosier1, L L Polla, J Tschopp
1Department of Medicine, Hôpital Cantonal Universitaire, Geneva, Switzerland.
The Journal of Investigative Dermatology
|April 1, 1990
Summary
Pulsed tunable dye laser (PTDL) therapy activates complement in normal skin and hemangiomas, leading to vascular necrosis. This complement activation, particularly the membrane attack complex (MAC), may drive the inflammatory response.
Area of Science:
- Immunology
- Dermatology
- Laser Therapy
Background:
- Pulsed tunable dye laser (PTDL) therapy causes hemoglobin coagulation and tissue necrosis, primarily in blood vessels.
- The role of complement system activation in PTDL-induced vascular damage is not fully understood.
Purpose of the Study:
- To investigate whether PTDL treatment activates the complement system in normal skin and senile hemangiomas.
- To analyze complement deposition in blood vessels following PTDL irradiation.
Main Methods:
- Immunofluorescence analysis of complement deposition (C3 fragments, C8, C9, MAC) in normal skin and hemangioma tissues.
- Assessment of alternative pathway complement activation using C4-deficient guinea pig serum.
- Comparison of complement deposition timing with transferrin deposition.
Main Results:
- PTDL irradiation led to deposition of C3 fragments, C8, C9, and MAC in vessel walls of normal skin.
- Complement activation via the alternative pathway was observed and specific to PTDL treatment.
- In hemangiomas, complement deposition was similar to normal skin, with some vessels showing immediate MAC assembly.
Conclusions:
- PTDL therapy activates the complement system, including the membrane attack complex (MAC), in irradiated blood vessels.
- Complement activation is implicated in PTDL-induced vascular necrosis and may contribute to the inflammatory response.
- Findings suggest complement activation is a key mechanism in PTDL's therapeutic effect and potential side effects.